aspirin has been researched along with 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, M; Blumberg, RS; Glickman, JN; Hong, S; Petasis, NA; Serhan, CN; Tjonahen, E; Yoshida, M | 1 |
| Arita, M; Clish, CB; Serhan, CN | 1 |
| Schwab, JM; Serhan, CN | 1 |
| Serhan, CN | 1 |
| Van Dyke, TE | 1 |
| Bannenberg, GL | 1 |
| Arita, M; Seki, H; Tani, Y | 1 |
| Conte, MS; Creager, MA; Ho, KJ; Kroemer, AH; Lancero, H; Owens, CD; Pande, R; Serhan, CN; Spite, M | 1 |
| Fortin, S; Hiram, R; Marouan, S; Morin, C; Rizcallah, E; Rousseau, E; Sirois, C; Sirois, M | 1 |
6 review(s) available for aspirin and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid
| Article | Year |
|---|---|
The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids.
Topics: Animals; Aspirin; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Oxygenases | 2005 |
Lipoxins and new lipid mediators in the resolution of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation; Lipid Metabolism; Lipoxins; Signal Transduction | 2006 |
Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; CD59 Antigens; Complement Inactivating Agents; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Inflammation; Neuroprotective Agents | 2006 |
Control of inflammation and periodontitis.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Aspirin; Biofilms; Bone Regeneration; Disease Susceptibility; Eicosapentaenoic Acid; Humans; Inflammation; Lipoxins; Periodontitis | 2007 |
Resolvins: Current understanding and future potential in the control of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation; Lipoxins; Molecular Structure; Signal Transduction; Structure-Activity Relationship | 2009 |
Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell Adhesion Molecules; Docosahexaenoic Acids; Eicosapentaenoic Acid; Exudates and Transudates; Fatty Acids, Omega-3; Humans; Inflammation; Mononuclear Phagocyte System; Phagocytes | 2009 |
3 other study(ies) available for aspirin and 5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid
| Article | Year |
|---|---|
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Aspirin; Colitis, Ulcerative; DNA Primers; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Immunoglobulin G; Interleukin-12; Interleukin-12 Subunit p40; Leukocytes; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Protein Subunits; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2005 |
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
Topics: Adaptor Proteins, Signal Transducing; Aged; Anti-Inflammatory Agents; Aspirin; Atherosclerosis; Blotting, Western; Case-Control Studies; Cell Survival; Chemotaxis; Eicosapentaenoic Acid; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Lipoxins; Male; Middle Aged; Muscle, Smooth, Vascular; Peripheral Arterial Disease; Phenotype; Phosphorylation; Platelet-Derived Growth Factor; Prospective Studies; Receptors, Chemokine; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saphenous Vein | 2010 |
Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium; Cell Movement; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Hypertension, Pulmonary; In Vitro Techniques; Indoles; Inflammation Mediators; Interleukin-6; Lipoxygenase Inhibitors; Matrix Metalloproteinase 9; Models, Biological; Monoglycerides; Myocytes, Smooth Muscle; Pulmonary Artery; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vasoconstriction | 2015 |